See referenced original article on pages 5955–63, this issue.
The prostate cancer conundrum revisited: Further insights†
Version of Record online: 26 JUN 2012
Copyright © 2012 American Cancer Society
Volume 118, Issue 23, pages 5724–5727, 1 December 2012
How to Cite
Albertsen, P. (2012), The prostate cancer conundrum revisited: Further insights. Cancer, 118: 5724–5727. doi: 10.1002/cncr.27718
- Issue online: 19 NOV 2012
- Version of Record online: 26 JUN 2012
- Manuscript Accepted: 4 JUN 2012
- Manuscript Received: 27 MAY 2012
Prostate cancer incidence and mortality trends in the United States continue to perplex researchers. The rise and subsequent decline in prostate cancer incidence can clearly be traced to the introduction of prostate-specific antigen testing. However, prostate cancer mortality rates have fallen sooner and faster than can be attributed to the impact of surgery and radiotherapy. Computer modeling by the National Cancer Institute's Cancer Intervention and Surveillance Modeling Network (CISNET) research teams provides insights into these complex relationships.